Dr. Freya Schnabel performs breast surgery.
Photo: Adam Watt
Breast surgeons at 嘿嘿视频鈥檚 are taking major steps to improve outcomes for their patients. Using a device called MarginProbe, doctors can scan the outer edges of excised tissue to ensure they are free and clear of any suspicious cells. This helps 嘿嘿视频 and other institutions across the globe eliminate the need for follow-up procedures鈥攁n often worrisome part of breast cancer treatment.聽
, director of breast surgery at Perlmutter Cancer Center, conducted the original clinical trials on MarginProbe that led to its FDA approval. 鈥淢arginProbe allows us to increase the likelihood that patients will leave the OR with a successful lumpectomy,鈥 Dr. Schnabel tells The Wall Street Journal. 鈥淭his technology is a real advance, and represents a further refinement of the lumpectomy procedure.鈥
MarginProbe is a wand-like device about the size of an electric toothbrush. The surgeon runs the device around the edges of excised tissue, and the attached monitor then indicates to the surgeon if the margins are clean or if there are still cancer cells present. If cells remain, the surgeon removes additional tissue while the patient is still on the operating table鈥攁ll but eliminating the need for additional surgery.
Read more from (subscription required).
